Polymorphisms in the RANK/RANKL Genes and Their Effect on Bone Specific Prognosis in Breast Cancer Patients

Polymorphisms in the RANK/RANKL Genes and Their Effect on Bone Specific Prognosis in Breast Cancer Patients

The receptor activator of NF-κB (RANK) pathway is involved in bone health as well as breast cancer (BC) pathogenesis and progression. Whereas the therapeutic implication of this pathway is established for the treatment of osteoporosis and bone metastases, the application in adjuvant BC is currently...

Full description

Bibliographic Details
Main Authors: Alexander Hein, Christian M. Bayer, Michael G. Schrauder, Lothar Häberle, Katharina Heusinger, Reiner Strick, Matthias Ruebner, Michael P. Lux, Stefan P. Renner, Rüdiger Schulz-Wendtland, Arif B. Ekici, Arndt Hartmann, Matthias W. Beckmann, Peter A. Fasching
Format: Article
Language:English
Published: Hindawi Limited 2014-01-01
Series:BioMed Research International
Online Access:http://dx.doi.org/10.1155/2014/842452

Internet

http://dx.doi.org/10.1155/2014/842452

Similar Items